60-OR: Sitagliptin for the Prevention and Treatment of Perioperative Hyperglycemia in Diabetic Patients Undergoing Cardiac Surgery

Perioperative hyperglycemia (BG >180 mg/dl) is reported in more than 80% of patients with T2D after cardiac surgery and is associated with high morbidity and mortality. Continuous insulin infusion (CII), the recommended for treatment of perioperative hyperglycemia is labor intensive and is associ...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2019-06, Vol.68 (Supplement_1)
Hauptverfasser:	CARDONA, SAUMETH, TSEGKA, KATERINA G., JACOBS, SOL, ALBURY, BONNIE S., GALINDO, RODOLFO J., MIGDAL, ALEXANDRA, HALKOS, MICHAEL E., KEELING, WILLIAM B., MILLER, JEFFREY S., MACHEERS, STEVEN K., GUYTON, ROBERT A., VELLANKI, PRIYATHAMA, DAVIS, GEORGIA, FAYFMAN, MAYA, PENG, LIMIN, PASQUEL, FRANCISCO J., UMPIERREZ, GUILLERMO E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Diabetes mellitus Heart Heart surgery Hyperglycemia Hypoglycemia Insulin Morbidity Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!